Archive for 2017

Do Patents Drive or Hinder Innovation?

Here’s a brief note in response to some of the discussions I’ve seen regarding the merit of patents. Many of the anti-patent arguments focus on things which probably never should have been patented. But few address the things which only exist because of patents. In some industries (e.g. software), patents are often seen as a […]


New patent expiration for Mallinckrodt Hosp drug INOMAX

Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent expiration for Mallinckrodt Hosp drug INOMAX …


Biotechblog